DEA eases requirements for natural cannabis-derived drug research

(Reuters) - The U.S Drug Enforcement Administration (DEA) on Wednesday relaxed some restrictions on research evaluating cannabidiol, an extract of the marijuana plant, for medicinal use.

http://ift.tt/1NLWkYU

from Reuters: Health News
via animenewspro